Antibodies News and Research

RSS

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

A molecule in mosquito spit has been identified as a potential new target for vaccination against a range of diseases for which there is no protection or medicine.

8 Jun 2022

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Researchers assessed the proportion of receptor-binding domain antibodies in COVID-19-recovered patients.

8 Jun 2022

Open multiplexing with Cell DIVE offers cancer researchers more choices

Leica has introduced a new generation of its multiplexed imaging solution, Cell DIVE, including software and hardware improvements. The more scalable and efficient multiplexing platform addresses spatial cell biology and function within the tissue microenvironment

From Leica Microsystems GmbH 8 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

Researchers evaluated the impact of breakthrough infections with SARS-CoV-2 Omicron BA.1 sublineage on SARS-CoV-2 variants of concern neutralization and memory B lymphocytes formation among BNT162b2 vaccinees.

7 Jun 2022

De novo-designed mini-protein against SARS-CoV-2

Researchers characterized truncated forms of LCB1, a de novo-designed mini-protein, against SARS-CoV-2.

7 Jun 2022

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Researchers observed SARS-CoV-2 seroconversion in lactating cows.

7 Jun 2022

Omicron lineage spike proteins use ACE2 receptors more efficiently

A recent study posted to the bioRxiv* preprint server demonstrated various traits, including the entry pathways and sensitivity to vaccination-elicited antibody responses by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants.

7 Jun 2022

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

7 Jun 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Chemo-immunotherapy combination shows promise against pancreatic cancer

A combination of chemotherapy with an immunotherapy meant to unleash the anticancer capacity of the immune system was effective against one of the hardest targets in cancer care, pancreatic cancer, in a national, randomized clinical trial led by researchers at the Perelman School of Medicine at the University of Pennsylvania, and sponsored by the Parker Institute for Cancer Immunotherapy.

6 Jun 2022

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.

From Bruker Cellular Analysis 6 Jun 2022

Persistence of viral RNA following acute infection

Professor Diane Griffin from the Johns Hopkins Bloomberg School of Public Health, USA, has recently explained the persistence mechanism of viral RNA in the human body after clinical recovery from acute infection.

6 Jun 2022

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reviewed and analyzed data from SARS-CoV-2 serosurveys supported by the United States Centers for Disease Prevention and Control in the low- and middle-income countries.

6 Jun 2022

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Antibodies News and Research

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Open multiplexing with Cell DIVE offers cancer researchers more choices

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

De novo-designed mini-protein against SARS-CoV-2

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Omicron lineage spike proteins use ACE2 receptors more efficiently

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Chemo-immunotherapy combination shows promise against pancreatic cancer

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Persistence of viral RNA following acute infection

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Truncated tau protein may be a means for better diagnosis and treatment of Alzheimer's disease

New HSS study clarifies the clinical manifestations of undifferentiated connective tissue disease

Scientists characterize a novel zoonotic coronavirus in humans

A new way of characterising biomolecules eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News